Pramlintide is a diabetes drug.

普兰林肽是一种糖尿病治疗药物。

youdao

Amylin Pharmaceuticals Inc. of San Diego, which bought the rights to leptin from Amgen Inc. in 2006, is testing it, in combination with pramlintide, a diabetes drug.

圣地亚哥的Amylin Pharmaceuticals Inc。于2006年从Amgen Inc。购买了瘦素的专利权，目前正在对瘦素和糖尿病药物普兰林（月太）联合作用的效果进行试验。

youdao

Early clinical data for another Amylin candidate, Pramlintide, also shows potential for use as a weight-loss agent.

FORBES: Magazine Article